138 results
Page 2 of 7
8-K
EX-1.1
qan kk5ztdd0
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
424B5
2ccca2g
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
1nzqudkt9m
13 Sep 22
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.2
0l0la60j5s
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
S-8
EX-23.2
3hohzhcd
12 Aug 22
Registration of securities for employees
8:23am
424B3
v90se
11 Jul 22
Prospectus supplement
4:32pm
POS AM
EX-23.1
nv1qpqqlo6vshmcrw
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
POS AM
gy07q1vpiv sm7
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
EX-4.6
naelet5l
1 Jul 22
Shelf registration
4:13pm
S-3
EX-23.1
e2p5 cj6ze
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
mzx jnssviso
1 Jul 22
Shelf registration
4:13pm
S-3
EX-5.1
g7tc o8vo
1 Jul 22
Shelf registration
4:13pm
S-3
l616aj4h0
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
raopieu5le kpf4
1 Jul 22
Shelf registration
4:13pm
8-K
sug b3hjy
3 Jun 22
Submission of Matters to a Vote of Security Holders
1:21pm
DEF 14A
721wxf4ed7eb
28 Apr 22
Definitive proxy
8:36am
424B3
goesm3l7ldlox
31 Mar 22
Prospectus supplement
11:42am
POS AM
EX-23.1
kcxj96 niw
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
POS AM
t7ly0z opw2z9qjdk8z
25 Mar 22
Prospectus update (post-effective amendment)
8:41am